New Tool Sheds Light on the Role of BCRP Protein in Drug-Drug Interactions Researchers must now take a serious look at drug transporter proteins because of a 2006 FDA draft guidance document: Guidance ...

SHIRLEY, NY, USA, July 1, 2024 /EINPresswire.com/ -- As a leading provider of innovative drug development services, Creative Bioarray is pleased to announce the ...

BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of ...

Creative Bioarray offers a variety of in vitro permeability and transporter assays, including the Caco-2 permeability assay, the MDCK permeability assay, the parallel artificial membrane permeability ...

While new drug molecules are typically tested in vivo in two preclinical species to better understand how they are transported and eliminated by the kidney and assess the risk of renal toxicity in ...